News & Media

This EOM Pharmaceuticals website may contain information, news, and/or press releases, the content of which is accurate or current only as of the date of the particular information, news, press release, or posting. EOM does not update press releases once they have been made public.

Media Kit

News Highlights

Press Release

EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.

November 10, 2022

Montvale, NJ – November 10, 2022 – EOM Pharmaceutical Holdings, Inc. (“EOM”), a clinical-stage pharmaceutical company, today announced its name change from ImmunoCellular Therapeutics Ltd., to EOM Pharmaceutical Holdings, Inc. EOM’s Common Stock will continue to be quoted on the OTC Markets under the ticker symbol “IMUC” while the company completes the process of changing […]

READ MORE »

Press Releases

November 10, 2022

EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.

DOWNLOAD